Results 151 to 160 of about 1,071,631 (269)

Mitochondrial dynamics and cancer: mechanisms and targeted therapy. [PDF]

Cell Biol Toxicol
Wang A, Ye X, Zhao Y, Zhang C.
europepmc   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Dual-targeted therapy with risankizumab and upadacitinib in medically complex Crohn's disease. [PDF]

Crohns Colitis 360
Fear EN, McDonald BD, Kennedy MS, Mathew AJ, McMillan RH, Fine ZD, McDermott AR, Choi D, Kellar A, Rubin DT.   +9 more
europepmc   +1 more source

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

Molecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano, Giuseppina Minopoli, Simona Romano, Laura Marrone, Katia Aquilano, Maria Lina Tornesello, Raffaella Faraonio   +6 more
wiley   +1 more source

Harnessing lentiviral vectors for in vivo gene therapy of liver metastases

Clinical and Translational Medicine
Giovanna Giacca, Luigi Naldini, Mario Leonardo Squadrito   +2 more
doaj   +1 more source

The role of radiotherapy in patients with advanced melanoma failing targeted therapy. [PDF]

Acta Oncol
Heurlin E, Grödeberg L, Helgadottir H.
europepmc   +1 more source

Engineered extracellular vesicles enriched with the miR‐214/199a cluster enhance the efficacy of chemotherapy in ovarian cancer

Molecular Oncology, EarlyView.
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang, Ayesha Alvero, Yi Qin, Mingjin Wang, Alexandra Fox, Yanfeng Li, Michael Millman, Amy Kemper, Gil Mor, Xian Shuang Liu, Michael Chopp, Zheng Gang Zhang, Yi Zhang   +12 more
wiley   +1 more source

Targeted Therapy for Hypertension in Pregnancy: Hemodynamics as a Therapeutic Compass. [PDF]

JACC Adv
Ceulemans M, Heremans R, Ghossein C, Gyselaers W.   +3 more
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Targeted Therapy in Erdheim-Chester Disease: A Case Report and Review of the Literature. [PDF]

Cureus
Alromdhan A, Ammakola Y, Cantu Soriano G, Rehman W, Fullmer J, Chisti M.   +5 more
europepmc   +1 more source